PASITHEA THERAPEUTICS CORP. Disposal Group, Including Discontinued Operation, Operating Income (Loss)
PASITHEA THERAPEUTICS CORP. (KTTA) reported Disposal Group, Including Discontinued Operation, Operating Income (Loss) of -$518.96 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss · last filed 2025-03-24
- PASITHEA THERAPEUTICS CORP. disposal group, including discontinued operation, operating income (loss) for the quarter ending 2023-12-31 was -$16.89K.
- PASITHEA THERAPEUTICS CORP. disposal group, including discontinued operation, operating income (loss) for the quarter ending 2023-09-30 was $0.00.
- PASITHEA THERAPEUTICS CORP. disposal group, including discontinued operation, operating income (loss) for the quarter ending 2023-06-30 was -$165.15K.
- PASITHEA THERAPEUTICS CORP. disposal group, including discontinued operation, operating income (loss) for the quarter ending 2023-03-31 was -$271.87K.
- PASITHEA THERAPEUTICS CORP. disposal group, including discontinued operation, operating income (loss) for fiscal 2023 was -$518.96K.
- PASITHEA THERAPEUTICS CORP. disposal group, including discontinued operation, operating income (loss) for fiscal 2022 was -$2.23M.
| Period end | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 3 month | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 6 month | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 9 month | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$16.89K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$16.89K derived: sum of 2 quarters · filed 2025-03-24 | -$182.04K derived: sum of 3 quarters · filed 2025-03-24 | -$518.96K 10-K · filed 2025-03-24 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$165.15K derived: sum of 2 quarters · filed 2024-11-13 | -$502.06K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | -$165.15K 10-Q · filed 2024-08-13 | -$502.06K 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | -$271.87K 10-Q · filed 2024-05-14 | |||
| 2022-12-31 | -$2.23M 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |